NANPING, China, Sept. 9, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovative China-based nutraceutical and dietary supplements producer, announced today that the Company has set up a wholly owned subsidiary "Happy Buy (Fujian) Internet Technology Co., Ltd."("Happy Buy") focusing on further developing the Companys e-Commerce business.

Happy Buy will carry out a unique B2B e-commerce model, utilizing the Companys advantages in supply chain and sales terminals, and leveraging various e-commerce forms to promote the sales of the Companys products to various online distributors. Management also expects to provide e-commerce and online marketing solutions to other small and media business via Happy Buy.

"During the period our business was impacted by the COVID-19, we have carried out a variety of e-commerce attempts and achieved gratifying results, which has strengthened the Companys determination to vigorously develop our own e-commerce business. Upon in-depth market research and comprehensive consideration, management decided to use the B2B model, as management believes the B2B model can maximize the companys existing resources and channel advantages. We have recruited managers and professionals with rich experience in e-commerce. We believe that, with the reputation and brand influence accumulated by Happiness Biotech over the past years, Happy Buy will shine in the field of e-commerce in the near future" said Mr. Xuezhu Wang, CEO of the Company.

about Happiness Biotech Group Limited

Headquartered in Nanping, China, Happiness Biotech Group Limited is an innovative China-based nutraceutical and dietary supplements producer focused on the research, development, manufacturing and marketing of a variety of products made from Chinese herbal extracts and other ingredients. The Companys goal is to provide high-quality products to our consumers. Over the past 14 years, the Company has established a product portfolio consisting of 32 CFDA registered "Blue-Cap" SKUs of nutraceutical and dietary supplements products. For more information, please visit: www.happ.org.cn.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Companys expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following:  the Companys goals and strategies; the Companys future business development; product and service demand and acceptance; changes in technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China; the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission.  For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Companys filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.